Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant

被引：2
|
作者：
Salem, R. [1 ,2 ]
Massoud, R. [1 ,2 ]
Haffar, B. [1 ,2 ]
Mahfouz, R. [3 ]
Bazarbachi, A. [1 ,2 ]
El-Cheikh, J. [1 ,2 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Div Hematol & Oncol, Dept Internal Med, Beirut, Lebanon
[3] Amer Univ Beirut, Dept Pathol & Lab Med, Beirut, Lebanon
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期
关键词：
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; NUCLEOPHOSMIN;
D O I：
10.1038/bmt.2017.82
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1187 / 1190
页数：4
相关论文
共 50 条
  • [1] Dynamics of Molecular Response in AML Patients with NPM1 and FLT3 Mutations Undergoing Allogeneic Stem Cell Transplant
    Salem, Rana
    Massoud, Radwan
    Mahfouz, Rami
    Bazarbachi, Ali
    El Cheikh, Jean
    BLOOD, 2016, 128 (22)
  • [2] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    R Salem
    R Massoud
    B Haffar
    R Mahfouz
    A Bazarbachi
    J El-Cheikh
    Bone Marrow Transplantation, 2017, 52 : 1187 - 1190
  • [3] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    SalemRana, R.
    Massoud, R.
    Mahfouz, R.
    Bazarbachi, A.
    El-Cheikh, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S341 - S342
  • [4] Clinical relevance of NPM1 and FLT3 mutations in AML patients
    Blau, O.
    Baldus, C. D.
    Graul, K.
    Sindram, A.
    Thiel, E.
    Blau, I. W.
    ONKOLOGIE, 2010, 33 : 234 - 234
  • [5] NPM1 AND FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)
    Aguiar, E.
    Amorim, M.
    Gomes, M. P.
    Guimaraes, P.
    Trigo, F.
    Guimaraes, J. E.
    HAEMATOLOGICA, 2012, 97 : 507 - 508
  • [6] CHARACTERIZATION OF FLT3 AND NPM1 MUTATIONS IN 17,783 AML PATIENTS
    Adams, N.
    Fodrie, T.
    Neff, F.
    Cubbon, A.
    HAEMATOLOGICA, 2013, 98 : 27 - 28
  • [7] Comprehensive Characterization of FLT3 and NPM1 Mutations in AML Samples Using NGS
    Xie, Z.
    Carson, A. R.
    Klass, M.
    Hubbard, D.
    Cubbon, R.
    Miller, J. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 717 - 717
  • [8] Impact of Allogeneic Stem Cell Transplant on Outcomes of Patients with Acute Myeloid Leukemia Based on NPM1 and FLT3 Mutational Status
    Meleveedu, Kapil Sankar
    Sidiqi, M. Hasib
    Nadiminti, Kalyan
    Hefazi, Mehrdad
    Alkhateeb, Hassan B.
    Shah, Mithun V.
    Phelps, Amy
    He, Rong
    Viswanatha, David S.
    Dingli, David
    Patnaik, Mrinal M.
    Hogan, William J.
    Litzow, Mark R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [9] ANALYSIS OF THE FLT3-ITO AND NPM1 MUTATIONS IN AML PATIENTS WITH INTERMEDIATE RISK RECEIVING ALLOGENEIC STEM-CELL TRANSPLANTATION
    Ogasawara, M.
    Yamakawa, T.
    Katsura, Y.
    Shima, K.
    Matsukawa, T.
    Kanaya, M.
    Minauchi, K.
    Nakata, M.
    Ota, S.
    Imai, K.
    Hirano, T.
    Kobayashi, N.
    Kiyama, Y.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S297 - S297
  • [10] NPM1 and FLT3 mutations in acute myeloid leukemia
    Nahajevszky, S.
    Tordai, A.
    Szitvasi, A.
    Meggyesi, N.
    Adam, E.
    Kozma, A.
    Lueff, S.
    Lovas, N.
    Kapas, B.
    Matrai, Z.
    Sipos, A.
    Masszi, T.
    Andrikovics, H.
    BLOOD REVIEWS, 2007, 21 : S110 - S111
12345